The NCK1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji B lymphocyte cell line. This product provides a heterogeneous loss-of-function model for NCK1, enabling study of adaptor protein-mediated signaling in a lymphoblastoid background. Gene disruption is achieved via CRISPR/Cas9-mediated targeting of the NCK1 locus, resulting in a polyclonal pool of cells with diverse editing events, which collectively ablate NCK1 function without clonal selection.
The Raji cell line is an Epstein-Barr virus (EBV)-positive lymphoblastoid line established from a Burkitt lymphoma patient. Raji cells exhibit characteristics of mature B lymphocytes and are widely used to model B cell receptor (BCR) signaling, humoral immunity, and antigen presentation. Their EBV-immortalized status provides a robust, proliferative background for genetic manipulation, making them suitable for investigating oncogenic and immunological pathways intrinsic to B-cell malignancies.
NCK1 encodes a cytoplasmic adaptor protein that couples activated receptor tyrosine kinases and immunoreceptors to downstream effectors controlling actin cytoskeleton dynamics. Mechanistically, NCK1 bridges phosphorylated tyrosine motifs on receptors such as EGFR, PDGFR, and Ephrin receptors to SH2/SH3 domain-containing complexes that include PAK1, the WAVE regulatory complex (CYFIP1, NCKAP1, ABI2), and the Arp2/3 complex. This cascade promotes actin polymerization, driving cell migration, adhesion, and immune synapse formation. NCK1 is activated downstream of BCR and TCR engagement and functions in concert with VAV1 and SOS1 to mediate signal transduction. It is a critical node in pathways including BCR signaling, EGFR signaling, and FAK-dependent motility.
In Raji cells, NCK1 participates in BCR-dependent cytoskeletal rearrangements essential for immune synapse assembly and antigen uptake. Disruption of NCK1 in this EBV-positive Burkitt lymphoma model allows investigation of how adaptor protein networks influence B-cell transformation, survival, and motility. The polyclonal knockout population avoids artifacts from clonal variation and preserves a broad representation of editing events, enabling robust assessment of pathway dependencies without the confounding influence of single-clone phenotypes. This model is particularly relevant for dissecting the role of NCK1 in B-cell lymphoma pathogenesis and for identifying vulnerabilities that may be exploited therapeutically.
The NCK1 Knockout Raji Polyclonal Cells are suitable for a range of functional studies, including BCR signaling analysis, immune synapse characterization, and cell migration assays. Researchers can employ techniques such as Western blotting and phospho-signaling analysis to assess altered downstream kinase activity, flow cytometry to evaluate surface receptor expression and actin dynamics, and Transwell migration assays to quantify invasive potential. Co-immunoprecipitation studies can delineate NCK1-dependent protein interactions, while drug sensitivity profiling can identify resistance mechanisms associated with adaptor protein loss. This knockout model supports both basic mechanistic studies and translational research in immuno-oncology and B-cell lymphomas. For further details, please contact Ascent Research.
